Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global TB Vaccines Market Growth 2022-2028

  • LP 4743979
  • 107 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of TB Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global TB Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global TB Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States TB Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global TB Vaccines market, reaching US$ million by the year 2028. As for the Europe TB Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main TB Vaccines players cover Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, and China National Biotec Group, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of TB Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Immunotherapeutic Vaccines

Booster Vaccines

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals

Private Clinics

Research Institutes

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck & Co.,Inc

Sanofi Pasteur

Japan BCG Laboratory

China National Biotec Group

Serum Institute

India Pvt. Ltd

InterVax Ltd

GreenSignal

Bio Pharma Limited

Statens Serum Institut

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global TB Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for TB Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for TB Vaccines by Country/Region, 2017, 2022 & 2028

2.2 TB Vaccines Segment by Type

2.2.1 Immunotherapeutic Vaccines

2.2.2 Booster Vaccines

2.2.3 Others

2.3 TB Vaccines Sales by Type

2.3.1 Global TB Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global TB Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global TB Vaccines Sale Price by Type (2017-2022)

2.4 TB Vaccines Segment by Application

2.4.1 Hospitals

2.4.2 Private Clinics

2.4.3 Research Institutes

2.5 TB Vaccines Sales by Application

2.5.1 Global TB Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global TB Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global TB Vaccines Sale Price by Application (2017-2022)

3 Global TB Vaccines by Company

3.1 Global TB Vaccines Breakdown Data by Company

3.1.1 Global TB Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global TB Vaccines Sales Market Share by Company (2020-2022)

3.2 Global TB Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global TB Vaccines Revenue by Company (2020-2022)

3.2.2 Global TB Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global TB Vaccines Sale Price by Company

3.4 Key Manufacturers TB Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers TB Vaccines Product Location Distribution

3.4.2 Players TB Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for TB Vaccines by Geographic Region

4.1 World Historic TB Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global TB Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global TB Vaccines Annual Revenue by Geographic Region

4.2 World Historic TB Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global TB Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global TB Vaccines Annual Revenue by Country/Region

4.3 Americas TB Vaccines Sales Growth

4.4 APAC TB Vaccines Sales Growth

4.5 Europe TB Vaccines Sales Growth

4.6 Middle East & Africa TB Vaccines Sales Growth

5 Americas

5.1 Americas TB Vaccines Sales by Country

5.1.1 Americas TB Vaccines Sales by Country (2017-2022)

5.1.2 Americas TB Vaccines Revenue by Country (2017-2022)

5.2 Americas TB Vaccines Sales by Type

5.3 Americas TB Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC TB Vaccines Sales by Region

6.1.1 APAC TB Vaccines Sales by Region (2017-2022)

6.1.2 APAC TB Vaccines Revenue by Region (2017-2022)

6.2 APAC TB Vaccines Sales by Type

6.3 APAC TB Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe TB Vaccines by Country

7.1.1 Europe TB Vaccines Sales by Country (2017-2022)

7.1.2 Europe TB Vaccines Revenue by Country (2017-2022)

7.2 Europe TB Vaccines Sales by Type

7.3 Europe TB Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa TB Vaccines by Country

8.1.1 Middle East & Africa TB Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa TB Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa TB Vaccines Sales by Type

8.3 Middle East & Africa TB Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of TB Vaccines

10.3 Manufacturing Process Analysis of TB Vaccines

10.4 Industry Chain Structure of TB Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 TB Vaccines Distributors

11.3 TB Vaccines Customer

12 World Forecast Review for TB Vaccines by Geographic Region

12.1 Global TB Vaccines Market Size Forecast by Region

12.1.1 Global TB Vaccines Forecast by Region (2023-2028)

12.1.2 Global TB Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global TB Vaccines Forecast by Type

12.7 Global TB Vaccines Forecast by Application

13 Key Players Analysis

13.1 Merck & Co.,Inc

13.1.1 Merck & Co.,Inc Company Information

13.1.2 Merck & Co.,Inc TB Vaccines Product Offered

13.1.3 Merck & Co.,Inc TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck & Co.,Inc Main Business Overview

13.1.5 Merck & Co.,Inc Latest Developments

13.2 Sanofi Pasteur

13.2.1 Sanofi Pasteur Company Information

13.2.2 Sanofi Pasteur TB Vaccines Product Offered

13.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Pasteur Main Business Overview

13.2.5 Sanofi Pasteur Latest Developments

13.3 Japan BCG Laboratory

13.3.1 Japan BCG Laboratory Company Information

13.3.2 Japan BCG Laboratory TB Vaccines Product Offered

13.3.3 Japan BCG Laboratory TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Japan BCG Laboratory Main Business Overview

13.3.5 Japan BCG Laboratory Latest Developments

13.4 China National Biotec Group

13.4.1 China National Biotec Group Company Information

13.4.2 China National Biotec Group TB Vaccines Product Offered

13.4.3 China National Biotec Group TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 China National Biotec Group Main Business Overview

13.4.5 China National Biotec Group Latest Developments

13.5 Serum Institute

13.5.1 Serum Institute Company Information

13.5.2 Serum Institute TB Vaccines Product Offered

13.5.3 Serum Institute TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Serum Institute Main Business Overview

13.5.5 Serum Institute Latest Developments

13.6 India Pvt. Ltd

13.6.1 India Pvt. Ltd Company Information

13.6.2 India Pvt. Ltd TB Vaccines Product Offered

13.6.3 India Pvt. Ltd TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 India Pvt. Ltd Main Business Overview

13.6.5 India Pvt. Ltd Latest Developments

13.7 InterVax Ltd

13.7.1 InterVax Ltd Company Information

13.7.2 InterVax Ltd TB Vaccines Product Offered

13.7.3 InterVax Ltd TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 InterVax Ltd Main Business Overview

13.7.5 InterVax Ltd Latest Developments

13.8 GreenSignal

13.8.1 GreenSignal Company Information

13.8.2 GreenSignal TB Vaccines Product Offered

13.8.3 GreenSignal TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 GreenSignal Main Business Overview

13.8.5 GreenSignal Latest Developments

13.9 Bio Pharma Limited

13.9.1 Bio Pharma Limited Company Information

13.9.2 Bio Pharma Limited TB Vaccines Product Offered

13.9.3 Bio Pharma Limited TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bio Pharma Limited Main Business Overview

13.9.5 Bio Pharma Limited Latest Developments

13.10 Statens Serum Institut

13.10.1 Statens Serum Institut Company Information

13.10.2 Statens Serum Institut TB Vaccines Product Offered

13.10.3 Statens Serum Institut TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Statens Serum Institut Main Business Overview

13.10.5 Statens Serum Institut Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. TB Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. TB Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Immunotherapeutic Vaccines

Table 4. Major Players of Booster Vaccines

Table 5. Major Players of Others

Table 6. Global TB Vaccines Sales by Type (2017-2022) & (K Units)

Table 7. Global TB Vaccines Sales Market Share by Type (2017-2022)

Table 8. Global TB Vaccines Revenue by Type (2017-2022) & ($ million)

Table 9. Global TB Vaccines Revenue Market Share by Type (2017-2022)

Table 10. Global TB Vaccines Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global TB Vaccines Sales by Application (2017-2022) & (K Units)

Table 12. Global TB Vaccines Sales Market Share by Application (2017-2022)

Table 13. Global TB Vaccines Revenue by Application (2017-2022)

Table 14. Global TB Vaccines Revenue Market Share by Application (2017-2022)

Table 15. Global TB Vaccines Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global TB Vaccines Sales by Company (2020-2022) & (K Units)

Table 17. Global TB Vaccines Sales Market Share by Company (2020-2022)

Table 18. Global TB Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 19. Global TB Vaccines Revenue Market Share by Company (2020-2022)

Table 20. Global TB Vaccines Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers TB Vaccines Producing Area Distribution and Sales Area

Table 22. Players TB Vaccines Products Offered

Table 23. TB Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global TB Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global TB Vaccines Sales Market Share Geographic Region (2017-2022)

Table 28. Global TB Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global TB Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global TB Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global TB Vaccines Sales Market Share by Country/Region (2017-2022)

Table 32. Global TB Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global TB Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas TB Vaccines Sales by Country (2017-2022) & (K Units)

Table 35. Americas TB Vaccines Sales Market Share by Country (2017-2022)

Table 36. Americas TB Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas TB Vaccines Revenue Market Share by Country (2017-2022)

Table 38. Americas TB Vaccines Sales by Type (2017-2022) & (K Units)

Table 39. Americas TB Vaccines Sales Market Share by Type (2017-2022)

Table 40. Americas TB Vaccines Sales by Application (2017-2022) & (K Units)

Table 41. Americas TB Vaccines Sales Market Share by Application (2017-2022)

Table 42. APAC TB Vaccines Sales by Region (2017-2022) & (K Units)

Table 43. APAC TB Vaccines Sales Market Share by Region (2017-2022)

Table 44. APAC TB Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC TB Vaccines Revenue Market Share by Region (2017-2022)

Table 46. APAC TB Vaccines Sales by Type (2017-2022) & (K Units)

Table 47. APAC TB Vaccines Sales Market Share by Type (2017-2022)

Table 48. APAC TB Vaccines Sales by Application (2017-2022) & (K Units)

Table 49. APAC TB Vaccines Sales Market Share by Application (2017-2022)

Table 50. Europe TB Vaccines Sales by Country (2017-2022) & (K Units)

Table 51. Europe TB Vaccines Sales Market Share by Country (2017-2022)

Table 52. Europe TB Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe TB Vaccines Revenue Market Share by Country (2017-2022)

Table 54. Europe TB Vaccines Sales by Type (2017-2022) & (K Units)

Table 55. Europe TB Vaccines Sales Market Share by Type (2017-2022)

Table 56. Europe TB Vaccines Sales by Application (2017-2022) & (K Units)

Table 57. Europe TB Vaccines Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa TB Vaccines Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa TB Vaccines Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa TB Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa TB Vaccines Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa TB Vaccines Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa TB Vaccines Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa TB Vaccines Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa TB Vaccines Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of TB Vaccines

Table 67. Key Market Challenges & Risks of TB Vaccines

Table 68. Key Industry Trends of TB Vaccines

Table 69. TB Vaccines Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. TB Vaccines Distributors List

Table 72. TB Vaccines Customer List

Table 73. Global TB Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global TB Vaccines Sales Market Forecast by Region

Table 75. Global TB Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global TB Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas TB Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas TB Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC TB Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC TB Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe TB Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe TB Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa TB Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa TB Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global TB Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global TB Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 87. Global TB Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global TB Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global TB Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global TB Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 91. Global TB Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global TB Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 93. Merck & Co.,Inc Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. Merck & Co.,Inc TB Vaccines Product Offered

Table 95. Merck & Co.,Inc TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Merck & Co.,Inc Main Business

Table 97. Merck & Co.,Inc Latest Developments

Table 98. Sanofi Pasteur Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. Sanofi Pasteur TB Vaccines Product Offered

Table 100. Sanofi Pasteur TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Sanofi Pasteur Main Business

Table 102. Sanofi Pasteur Latest Developments

Table 103. Japan BCG Laboratory Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. Japan BCG Laboratory TB Vaccines Product Offered

Table 105. Japan BCG Laboratory TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Japan BCG Laboratory Main Business

Table 107. Japan BCG Laboratory Latest Developments

Table 108. China National Biotec Group Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. China National Biotec Group TB Vaccines Product Offered

Table 110. China National Biotec Group TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. China National Biotec Group Main Business

Table 112. China National Biotec Group Latest Developments

Table 113. Serum Institute Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 114. Serum Institute TB Vaccines Product Offered

Table 115. Serum Institute TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Serum Institute Main Business

Table 117. Serum Institute Latest Developments

Table 118. India Pvt. Ltd Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 119. India Pvt. Ltd TB Vaccines Product Offered

Table 120. India Pvt. Ltd TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. India Pvt. Ltd Main Business

Table 122. India Pvt. Ltd Latest Developments

Table 123. InterVax Ltd Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 124. InterVax Ltd TB Vaccines Product Offered

Table 125. InterVax Ltd TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. InterVax Ltd Main Business

Table 127. InterVax Ltd Latest Developments

Table 128. GreenSignal Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 129. GreenSignal TB Vaccines Product Offered

Table 130. GreenSignal TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. GreenSignal Main Business

Table 132. GreenSignal Latest Developments

Table 133. Bio Pharma Limited Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 134. Bio Pharma Limited TB Vaccines Product Offered

Table 135. Bio Pharma Limited TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Bio Pharma Limited Main Business

Table 137. Bio Pharma Limited Latest Developments

Table 138. Statens Serum Institut Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 139. Statens Serum Institut TB Vaccines Product Offered

Table 140. Statens Serum Institut TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Statens Serum Institut Main Business

Table 142. Statens Serum Institut Latest Developments

List of Figures

Figure 1. Picture of TB Vaccines

Figure 2. TB Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global TB Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global TB Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. TB Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Immunotherapeutic Vaccines

Figure 10. Product Picture of Booster Vaccines

Figure 11. Product Picture of Others

Figure 12. Global TB Vaccines Sales Market Share by Type in 2021

Figure 13. Global TB Vaccines Revenue Market Share by Type (2017-2022)

Figure 14. TB Vaccines Consumed in Hospitals

Figure 15. Global TB Vaccines Market: Hospitals (2017-2022) & (K Units)

Figure 16. TB Vaccines Consumed in Private Clinics

Figure 17. Global TB Vaccines Market: Private Clinics (2017-2022) & (K Units)

Figure 18. TB Vaccines Consumed in Research Institutes

Figure 19. Global TB Vaccines Market: Research Institutes (2017-2022) & (K Units)

Figure 20. Global TB Vaccines Sales Market Share by Application (2017-2022)

Figure 21. Global TB Vaccines Revenue Market Share by Application in 2021

Figure 22. TB Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 23. Global TB Vaccines Revenue Market Share by Company in 2021

Figure 24. Global TB Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global TB Vaccines Revenue Market Share by Geographic Region in 2021

Figure 26. Global TB Vaccines Sales Market Share by Region (2017-2022)

Figure 27. Global TB Vaccines Revenue Market Share by Country/Region in 2021

Figure 28. Americas TB Vaccines Sales 2017-2022 (K Units)

Figure 29. Americas TB Vaccines Revenue 2017-2022 ($ Millions)

Figure 30. APAC TB Vaccines Sales 2017-2022 (K Units)

Figure 31. APAC TB Vaccines Revenue 2017-2022 ($ Millions)

Figure 32. Europe TB Vaccines Sales 2017-2022 (K Units)

Figure 33. Europe TB Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa TB Vaccines Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa TB Vaccines Revenue 2017-2022 ($ Millions)

Figure 36. Americas TB Vaccines Sales Market Share by Country in 2021

Figure 37. Americas TB Vaccines Revenue Market Share by Country in 2021

Figure 38. United States TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC TB Vaccines Sales Market Share by Region in 2021

Figure 43. APAC TB Vaccines Revenue Market Share by Regions in 2021

Figure 44. China TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. India TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe TB Vaccines Sales Market Share by Country in 2021

Figure 51. Europe TB Vaccines Revenue Market Share by Country in 2021

Figure 52. Germany TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. France TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa TB Vaccines Sales Market Share by Country in 2021

Figure 58. Middle East & Africa TB Vaccines Revenue Market Share by Country in 2021

Figure 59. Egypt TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country TB Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of TB Vaccines in 2021

Figure 65. Manufacturing Process Analysis of TB Vaccines

Figure 66. Industry Chain Structure of TB Vaccines

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390